Ilya joined the RenalGuard team as CEO in 2021. He has over a decade of experience developing innovative products and strategic partnerships that address the needs of key stakeholders in the US and global healthcare market. As managing partner at Imagine Bio, he served as a trusted advisor to global pharma and MedTech leaders to develop and execute innovation strategies leveraging collaborations with emerging startups.
Previously, as CEO of NeuroQuest, he led the turn-around and clinic al validation of what emerged as a leading blood-based biomarker for Alzheimer’s Disease, recruited a global management team, secured capital, and attracted extensive in-kind funding through partnerships with key international players. He began his career in corporate finance at JNJ’s Ethicon Endo-Surgery.
Ilya studied finance and biochemistry at Miami University of Ohio, contributed to NSF sponsored research in organic and biochemistry at Ohio State University, and holds an executive certificate in Healthcare Entrepreneurship from Tel Aviv University.